UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

British journal of cancer, 2010-02, Vol.102 (3), p.506-512

2010

Volltextzugriff (PDF)

Safety of revaccination with pneumococcal polysaccharide vaccine

JAMA : the journal of the American Medical Association, 1999-01, Vol.281 (3), p.243

1999

Volltextzugriff (PDF)

Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma

Annals of oncology, 2003-01, Vol.14 (suppl-1), p.i17-i20

2003

Volltextzugriff (PDF)

Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—results from an expert meeting

Annals of oncology, 2003-01, Vol.14 (suppl-1), p.i1-i3

2003

Volltextzugriff (PDF)

7121 Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)

European journal of cancer supplements, 2009, Vol.7 (2), p.429-429

2009

Volltextzugriff (PDF)

7126 What is the impact of subsequent antineoplastic therapy on overall survival (OS) following first-line bevacizumab (BEV)/interferonalpha2a (IFN) in metastatic renal cell carcinoma (mRCC)? – Experience from AVOREN

European journal of cancer supplements, 2009, Vol.7 (2), p.431-431

2009

Volltextzugriff (PDF)

Use of a nomogram to quantify overall survival (OS) benefit in patients with metastatic renal cell carcinoma (mRCC) receiving bevacizumab (BEV) with interferon (IFN) versus IFN alone

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.4592-4592

2010

Volltextzugriff (PDF)

Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—resultsfrom an expert meeting

Annals of oncology, 2003-05, Vol.14, p.i1-i3

2003

Volltextzugriff (PDF)

Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race

Annals of internal medicine, 2003-06, Vol.138 (12), p.960

2003

Volltextzugriff (PDF)

Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma

Annals of oncology, 2004-03, Vol.15 (3), p.541-541

2004

Volltextzugriff (PDF)

BEVLiN: Prospective study of the safety and efficacy of first-line bevacizumab (BEV) plus low-dose interferon-α2a (IFN) in patients (pts) with metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4546-4546

2011

Volltextzugriff (PDF)

Use of standing orders programs to increase adult vaccination rates

MMWR. Recommendations and reports, 2000-03, Vol.49 (RR-1), p.15-16

2000

Volltextzugriff (PDF)

Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb

Wiener medizinische Wochenschrift, 1995, Vol.145 (2-3), p.61

1995

Volltextzugriff (PDF)

Brugia pahangi: Development in Aedes aegypti reared axenically on a defined synthetic diet

Experimental parasitology, 1981-01, Vol.51 (2), p.169-174

1981

Volltextzugriff (PDF)

Brugia pahangi: Growth improvement with lecithin in the diet of axenically reared hosts, Aedes aegypti

Experimental parasitology, 1981-01, Vol.51 (3), p.335-340

1981

Volltextzugriff (PDF)

Provider Response to Different Formats of the Adult Immunization Schedule

American journal of preventive medicine, 2005-07, Vol.29 (1), p.34-40

2005

Volltextzugriff (PDF)

Requirement for sugar in a chemically defined diet for larval Aedes aegypti (Diptera: Culicidae)

Journal of medical entomology, 1977-12, Vol.14 (4), p.387-392

1977

Volltextzugriff (PDF)

Inhibition of Dirofilaria immitis in gregarine-infected Aedes aegypti: Preliminary observations

Journal of invertebrate pathology, 1979-01, Vol.34 (1), p.62-70

Sneller, Vishnu-Priya

1979

Volltextzugriff (PDF)

Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination

Medical decision making, 2002-09, Vol.22 (1_suppl), p.58-66

2002

Volltextzugriff (PDF)

Human Rabies—Miami, 1994

JAMA : the journal of the American Medical Association, 1994-11, Vol.272 (19), p.1494

1994

Volltextzugriff (PDF)

In vitro development of Dirofilaria immitis microfilariae: Selection of culture media and serum levels

International journal for parasitology, 1982-06, Vol.12 (2), p.233-238

1982

Volltextzugriff (PDF)

2021 Mark Coventry Award: Use of a smartphone-based care platform after primary partial and total knee arthroplasty: a prospective randomized controlled trial

The bone & joint journal, 2021-06, Vol.103-B (6 Supple A), p.3-12

2021

Volltextzugriff (PDF)

Probable Transmission of Multidrug-Resistant Tuberculosis in Correctional Facility—California

JAMA : the journal of the American Medical Association, 1993-02, Vol.269 (8), p.978

1993

Volltextzugriff (PDF)

Two-stage Treatment of Hip Periprosthetic Joint Infection Is Associated With a High Rate of Infection Control but High Mortality

Clinical orthopaedics and related research, 2013-02, Vol.471 (2), p.510-518

2013

Volltextzugriff (PDF)

Lecithin in synthetic larval diet for Aedes aegypti improves larval and adult performance

Entomologia experimentalis et applicata, 1981, Vol.29 (1), p.9-18

1981

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancer

Safety of revaccination with pneumococcal polysaccharide vaccine

Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma

Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—results from an expert meeting

7121 Bevacizumab (BEV) and interferon (IFN) therapy does not increase risk of cardiac events in metastatic renal cell carcinoma (mRCC)

7126 What is the impact of subsequent antineoplastic therapy on overall survival (OS) following first-line bevacizumab (BEV)/interferonalpha2a (IFN) in metastatic renal cell carcinoma (mRCC)? – Experience from AVOREN

Use of a nomogram to quantify overall survival (OS) benefit in patients with metastatic renal cell carcinoma (mRCC) receiving bevacizumab (BEV) with interferon (IFN) versus IFN alone

Current role and future perspectives for ifosfamide in the treatment of malignant non-Hodgkin’s lymphoma—resultsfrom an expert meeting

Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race

Outpatient regimen rituximab plus ifosfamide, carboplatin and etoposide (R-ICE) for relapsed non-Hodgkin’s lymphoma

BEVLiN: Prospective study of the safety and efficacy of first-line bevacizumab (BEV) plus low-dose interferon-α2a (IFN) in patients (pts) with metastatic renal cell carcinoma (mRCC)

Use of standing orders programs to increase adult vaccination rates

Autologous bone marrow transplantation for haematological malignancies--experiences of the centre of Zagreb

Brugia pahangi: Development in Aedes aegypti reared axenically on a defined synthetic diet

Brugia pahangi: Growth improvement with lecithin in the diet of axenically reared hosts, Aedes aegypti

Provider Response to Different Formats of the Adult Immunization Schedule

Requirement for sugar in a chemically defined diet for larval Aedes aegypti (Diptera: Culicidae)

Inhibition of Dirofilaria immitis in gregarine-infected Aedes aegypti: Preliminary observations

Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination

Human Rabies—Miami, 1994

In vitro development of Dirofilaria immitis microfilariae: Selection of culture media and serum levels

2021 Mark Coventry Award: Use of a smartphone-based care platform after primary partial and total knee arthroplasty: a prospective randomized controlled trial

Probable Transmission of Multidrug-Resistant Tuberculosis in Correctional Facility—California

Two-stage Treatment of Hip Periprosthetic Joint Infection Is Associated With a High Rate of Infection Control but High Mortality

Lecithin in synthetic larval diet for Aedes aegypti improves larval and adult performance

Suchergebnisse filtern